Siveco to provide RON 16.1 mln IT system for the Romanian Government

Newsroom 30/12/2014 | 09:25

Romanian software producer Siveco will provide an IT system for optimizing internal internal at the General Secretariat of the Government (SGG), with a focus on improving SGG’s cooperation with other public administration institutions, in a contract worth RON 16.8 million (EUR 3.5 million), writes Mediafax

Siveco Romania’s bid was made in a joint venture with the Bucharest-based IT company Expert One Research. Two other joint took part in the auction, namely Power Net Consulting, Romair Consulting and Evolva Trend Consulting, respectively Computas IT Romania, Iquest Technologies, Cloud Soft, Digisign, Matrix Business Consulting and Software Business Union.

The contract is for 12 months and will be financed from the state budget and EU funds. Siveco will supply hardware and software components, as well as development and implementation services. Also included in the deal is a series of consultancy services in the field of project management.

Siveco was also recently selected to provide IT services for the European Union worth EUR 100 million, as part of a consortium that also includes IBM, Deloitte and Steria. 

“This marks the first time when a Romanian company is selected to supply services for all the General Directions within the European Commissions”, the company said at the time.

Siveco’s reputation took a heavy hit this year, along with most of Romania’s IT industry, seeing as serious charges of corruption, fraud and tax evasion were brought against it.

Local IT sector rocked by corruption scandals

 

BR Magazine | Latest Issue

Download PDF: Business Review Magazine December (II) 2023 Issue

The December (II) 2023 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “A Visionary Leader Entrusted With Consolidating CPI's Portfolio
Newsroom | 21/12/2023 | 14:13
Advertisement Advertisement
Close ×

We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

Accept & continue